Skip to content

Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts

Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05880628
Enrollment
30
Registered
2023-05-30
Start date
2022-04-14
Completion date
2024-12-31
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Cysts

Keywords

Bone Cysts, Aneurysmal Bone Cysts, simple Bone Cysts, Discogel, Effectiveness, Safety

Brief summary

There is no consensus in the scientific literature for the treatment of aneurysmal and simple bone cysts. Some scientific articles with utilisation of sclerosis agents for the treatment of aneurysmal bone cysts: Ethibloc no longer marketed, pure Ethanol, Aetoxisclerol.

Detailed description

The aim of this work is therefore the evaluation of Discogel® in the treatment of Discogel®, which appears to be a safe and efficacity of method.

Interventions

Analysis datas of medical record: * Feasibility of the technique * Safety of the technique * Efficacity (sclerose of the lesion)

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient with aneurysmal or simple bone cyst who benefit a sclerotherapy by Discogel

Exclusion criteria

* Refusal

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the techniqueYear: 2Collect from medical records the number of procedures that were completed and performed as theoretically intended.

Secondary

MeasureTime frameDescription
Safety of the technique by number of adverse eventYear: 2collect in the medical record
Number of discogel® injections by sclerose of the lesionYear: 2Efficacity of the technique

Countries

France

Contacts

Primary ContactSylvain Grange, MD
Sylvain.Grange@chu-st-etienne.fr(0)477829066
Backup ContactValentin Gineys, resident
Sylvain.Grange@chu-st-etienne.fr(0)477829066

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026